Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
TVRD
$1.79
+2.41%
TVRD
· Tvardi Therapeutics, Inc.
$1.79
+0.04 (+2.41%)
At close · Sep 2
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, the Company has concluded that management's plans do not alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$24.28M
Shares
13.34M
All earnings calls
Earnings call · FY2020 Q2
Tvardi Therapeutics, Inc. (TVRD) Q2 2020 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$5.63M
+8.2% YoY
Diluted EPS
-$19.44
Net income
-$25.07M
Research materials
Open the source you need; every reader stays inside this workspace.
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 10, 2020 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 10, 2020 · complete as-filed document